Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

The cost-effectiveness of the Manchester 'lung health checks', a community-based lung cancer low-dose CT screening pilot.

Hinde S, Crilly T, Balata H, Bartlett R, Crilly J, Barber P, Threlfall A, Tonge J, Booton R, Crosbie PA.

Lung Cancer. 2018 Dec;126:119-124. doi: 10.1016/j.lungcan.2018.10.029. Epub 2018 Nov 2.

PMID:
30527175
2.

Second round results from the Manchester 'Lung Health Check' community-based targeted lung cancer screening pilot.

Crosbie PA, Balata H, Evison M, Atack M, Bayliss-Brideaux V, Colligan D, Duerden R, Eaglesfield J, Edwards T, Elton P, Foster J, Greaves M, Hayler G, Higgins C, Howells J, Irion K, Karunaratne D, Kelly J, King Z, Lyons J, Manson S, Mellor S, Miller D, Myerscough A, Newton T, O'Leary M, Pearson R, Pickford J, Sawyer R, Screaton NJ, Sharman A, Simmons M, Smith E, Taylor B, Taylor S, Walsham A, Watts A, Whittaker J, Yarnell L, Threlfall A, Barber PV, Tonge J, Booton R.

Thorax. 2019 Jul;74(7):700-704. doi: 10.1136/thoraxjnl-2018-212547. Epub 2018 Nov 12.

3.

"To know or not to know…?" Push and pull in ever smokers lung screening uptake decision-making intentions.

Tonge JE, Atack M, Crosbie PA, Barber PV, Booton R, Colligan D.

Health Expect. 2019 Apr;22(2):162-172. doi: 10.1111/hex.12838. Epub 2018 Oct 5.

4.

Targeted lung cancer screening selects individuals at high risk of cardiovascular disease.

Balata H, Blandin Knight S, Barber P, Colligan D, Crosbie EJ, Duerden R, Elton P, Evison M, Greaves M, Howells J, Irion K, Karunaratne D, Kirwan M, Macnab A, Mellor S, Miller C, Newton T, Novasio J, Sawyer R, Sharman A, Slevin K, Smith E, Taylor B, Taylor S, Tonge J, Walsham A, Waplington S, Whittaker J, Booton R, Crosbie PAJ.

Lung Cancer. 2018 Oct;124:148-153. doi: 10.1016/j.lungcan.2018.08.006. Epub 2018 Aug 8.

PMID:
30268454
5.

KRAS induces lung tumorigenesis through microRNAs modulation.

Shi L, Middleton J, Jeon YJ, Magee P, Veneziano D, Laganà A, Leong HS, Sahoo S, Fassan M, Booton R, Shah R, Crosbie PAJ, Garofalo M.

Cell Death Dis. 2018 Feb 13;9(2):219. doi: 10.1038/s41419-017-0243-9.

6.

Implementing lung cancer screening: baseline results from a community-based 'Lung Health Check' pilot in deprived areas of Manchester.

Crosbie PA, Balata H, Evison M, Atack M, Bayliss-Brideaux V, Colligan D, Duerden R, Eaglesfield J, Edwards T, Elton P, Foster J, Greaves M, Hayler G, Higgins C, Howells J, Irion K, Karunaratne D, Kelly J, King Z, Manson S, Mellor S, Miller D, Myerscough A, Newton T, O'Leary M, Pearson R, Pickford J, Sawyer R, Screaton NJ, Sharman A, Simmons M, Smith E, Taylor B, Taylor S, Walsham A, Watts A, Whittaker J, Yarnell L, Threlfall A, Barber PV, Tonge J, Booton R.

Thorax. 2019 Apr;74(4):405-409. doi: 10.1136/thoraxjnl-2017-211377. Epub 2018 Feb 13.

PMID:
29440588
7.

Corrigendum: Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution.

Abbosh C, Birkbak NJ, Wilson GA, Jamal-Hanjani M, Constantin T, Salari R, Le Quesne J, Moore DA, Veeriah S, Rosenthal R, Marafioti T, Kirkizlar E, Watkins TBK, McGranahan N, Ward S, Martinson L, Riley J, Fraioli F, Al Bakir M, Grönroos E, Zambrana F, Endozo R, Bi WL, Fennessy FM, Sponer N, Johnson D, Laycock J, Shafi S, Czyzewska-Khan J, Rowan A, Chambers T, Matthews N, Turajlic S, Hiley C, Lee SM, Forster MD, Ahmad T, Falzon M, Borg E, Lawrence D, Hayward M, Kolvekar S, Panagiotopoulos N, Janes SM, Thakrar R, Ahmed A, Blackhall F, Summers Y, Hafez D, Naik A, Ganguly A, Kareht S, Shah R, Joseph L, Quinn AM, Crosbie PA, Naidu B, Middleton G, Langman G, Trotter S, Nicolson M, Remmen H, Kerr K, Chetty M, Gomersall L, Fennell DA, Nakas A, Rathinam S, Anand G, Khan S, Russell P, Ezhil V, Ismail B, Irvin-Sellers M, Prakash V, Lester JF, Kornaszewska M, Attanoos R, Adams H, Davies H, Oukrif D, Akarca AU, Hartley JA, Lowe HL, Lock S, Iles N, Bell H, Ngai Y, Elgar G, Szallasi Z, Schwarz RF, Herrero J, Stewart A, Quezada SA, Peggs KS, Van Loo P, Dive C, Lin CJ, Rabinowitz M, Aerts HJWL, Hackshaw A, Shaw JA, Zimmermann BG, Swanton C.

Nature. 2018 Feb 8;554(7691):264. doi: 10.1038/nature25161. Epub 2017 Dec 20.

PMID:
29258292
8.

Progress and prospects of early detection in lung cancer.

Blandin Knight S, Crosbie PA, Balata H, Chudziak J, Hussell T, Dive C.

Open Biol. 2017 Sep;7(9). pii: 170070. doi: 10.1098/rsob.170070. Review.

9.

Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution.

Abbosh C, Birkbak NJ, Wilson GA, Jamal-Hanjani M, Constantin T, Salari R, Le Quesne J, Moore DA, Veeriah S, Rosenthal R, Marafioti T, Kirkizlar E, Watkins TBK, McGranahan N, Ward S, Martinson L, Riley J, Fraioli F, Al Bakir M, Grönroos E, Zambrana F, Endozo R, Bi WL, Fennessy FM, Sponer N, Johnson D, Laycock J, Shafi S, Czyzewska-Khan J, Rowan A, Chambers T, Matthews N, Turajlic S, Hiley C, Lee SM, Forster MD, Ahmad T, Falzon M, Borg E, Lawrence D, Hayward M, Kolvekar S, Panagiotopoulos N, Janes SM, Thakrar R, Ahmed A, Blackhall F, Summers Y, Hafez D, Naik A, Ganguly A, Kareht S, Shah R, Joseph L, Marie Quinn A, Crosbie PA, Naidu B, Middleton G, Langman G, Trotter S, Nicolson M, Remmen H, Kerr K, Chetty M, Gomersall L, Fennell DA, Nakas A, Rathinam S, Anand G, Khan S, Russell P, Ezhil V, Ismail B, Irvin-Sellers M, Prakash V, Lester JF, Kornaszewska M, Attanoos R, Adams H, Davies H, Oukrif D, Akarca AU, Hartley JA, Lowe HL, Lock S, Iles N, Bell H, Ngai Y, Elgar G, Szallasi Z, Schwarz RF, Herrero J, Stewart A, Quezada SA, Peggs KS, Van Loo P, Dive C, Lin CJ, Rabinowitz M, Aerts HJWL, Hackshaw A, Shaw JA, Zimmermann BG; TRACERx consortium; PEACE consortium, Swanton C.

Nature. 2017 Apr 26;545(7655):446-451. doi: 10.1038/nature22364. Erratum in: Nature. 2017 Dec 20;:.

10.

Tracking the Evolution of Non-Small-Cell Lung Cancer.

Jamal-Hanjani M, Wilson GA, McGranahan N, Birkbak NJ, Watkins TBK, Veeriah S, Shafi S, Johnson DH, Mitter R, Rosenthal R, Salm M, Horswell S, Escudero M, Matthews N, Rowan A, Chambers T, Moore DA, Turajlic S, Xu H, Lee SM, Forster MD, Ahmad T, Hiley CT, Abbosh C, Falzon M, Borg E, Marafioti T, Lawrence D, Hayward M, Kolvekar S, Panagiotopoulos N, Janes SM, Thakrar R, Ahmed A, Blackhall F, Summers Y, Shah R, Joseph L, Quinn AM, Crosbie PA, Naidu B, Middleton G, Langman G, Trotter S, Nicolson M, Remmen H, Kerr K, Chetty M, Gomersall L, Fennell DA, Nakas A, Rathinam S, Anand G, Khan S, Russell P, Ezhil V, Ismail B, Irvin-Sellers M, Prakash V, Lester JF, Kornaszewska M, Attanoos R, Adams H, Davies H, Dentro S, Taniere P, O'Sullivan B, Lowe HL, Hartley JA, Iles N, Bell H, Ngai Y, Shaw JA, Herrero J, Szallasi Z, Schwarz RF, Stewart A, Quezada SA, Le Quesne J, Van Loo P, Dive C, Hackshaw A, Swanton C; TRACERx Consortium.

N Engl J Med. 2017 Jun 1;376(22):2109-2121. doi: 10.1056/NEJMoa1616288. Epub 2017 Apr 26.

11.

Circulating Tumor Cells Detected in the Tumor-Draining Pulmonary Vein Are Associated with Disease Recurrence after Surgical Resection of NSCLC.

Crosbie PA, Shah R, Krysiak P, Zhou C, Morris K, Tugwood J, Booton R, Blackhall F, Dive C.

J Thorac Oncol. 2016 Oct;11(10):1793-7. doi: 10.1016/j.jtho.2016.06.017. Epub 2016 Jul 25.

12.

ERK and AKT phosphorylation status in lung cancer and emphysema using nanocapillary isoelectric focusing.

Crosbie PA, Crosbie EJ, Aspinall-O'Dea M, Walker M, Harrison R, Pernemalm M, Shah R, Joseph L, Booton R, Pierce A, Whetton AD.

BMJ Open Respir Res. 2016 Feb 17;3(1):e000114. doi: 10.1136/bmjresp-2015-000114. eCollection 2016.

13.

Endobronchial ultrasound images: bronchial artery and pulmonary emboli.

Evison M, Crosbie PA, Booton R, Barber P.

J Bronchology Interv Pulmonol. 2015 Apr;22(2):142-4. doi: 10.1097/LBR.0000000000000141. No abstract available.

PMID:
25887011
14.

Can EBUS-TBNA provide an accurate diagnosis in patients found to have enlarged or FDG-avid lymph nodes during surveillance of previously treated lung cancer? A retrospective study.

Evison M, Crosbie PA, Califano R, Summers Y, Martin J, Barber PV, Booton R.

J Bronchology Interv Pulmonol. 2015 Apr;22(2):114-20. doi: 10.1097/LBR.0000000000000154.

PMID:
25887006
15.

Molecular histology of lung cancer: from targets to treatments.

Wood SL, Pernemalm M, Crosbie PA, Whetton AD.

Cancer Treat Rev. 2015 Apr;41(4):361-75. doi: 10.1016/j.ctrv.2015.02.008. Epub 2015 Feb 20. Review.

PMID:
25825324
16.

Achieving a tissue diagnosis in PS3 patients with advanced lung cancer: what are the safety and diagnostic outcomes with EBUS?

Al-Najjar H, Evison M, Crosbie PA, Martin J, Barber PV, Booton R.

Lung Cancer. 2015 May;88(2):236-7. doi: 10.1016/j.lungcan.2015.03.001. Epub 2015 Mar 9. No abstract available.

PMID:
25783565
17.

Thoracic metastasis from renal cell carcinoma: bronchoscopic and EBUS images.

Evison M, Crosbie PA, Booton R.

J Bronchology Interv Pulmonol. 2015 Jan;22(1):55-7. doi: 10.1097/LBR.0000000000000124. No abstract available.

PMID:
25590485
18.

A study of patients with isolated mediastinal and hilar lymphadenopathy undergoing EBUS-TBNA.

Evison M, Crosbie PA, Morris J, Martin J, Barber PV, Booton R.

BMJ Open Respir Res. 2014 May 31;1(1):e000040. doi: 10.1136/bmjresp-2014-000040. eCollection 2014. Erratum in: BMJ Open Respir Res. 2014;1(1):e000040corr1.

19.

Nodal staging in lung cancer: a risk stratification model for lymph nodes classified as negative by EBUS-TBNA.

Evison M, Morris J, Martin J, Shah R, Barber PV, Booton R, Crosbie PA.

J Thorac Oncol. 2015 Jan;10(1):126-33. doi: 10.1097/JTO.0000000000000348.

20.

Can computed tomography characteristics predict outcomes in patients undergoing radial endobronchial ultrasound-guided biopsy of peripheral lung lesions?

Evison M, Crosbie PA, Morris J, Martin J, Barber PV, Booton R.

J Thorac Oncol. 2014 Sep;9(9):1393-7. doi: 10.1097/JTO.0000000000000249.

21.

EBUS-TBNA in elderly patients with lung cancer: safety and performance outcomes.

Evison M, Crosbie PA, Martin J, Bishop P, Doran H, Joseph L, Chaturvedi A, Barber PV, Booton R.

J Thorac Oncol. 2014 Mar;9(3):370-6. doi: 10.1097/JTO.0000000000000085.

22.

Cerebral air embolism following transbronchial lung biopsy during flexible bronchoscopy.

Evison M, Crosbie PA, Bright-Thomas R, Alaloul M, Booton R.

Respir Med Case Rep. 2014 Mar 28;12:39-40. doi: 10.1016/j.rmcr.2013.10.005. eCollection 2014.

23.

The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets.

Wood SL, Pernemalm M, Crosbie PA, Whetton AD.

Cancer Treat Rev. 2014 May;40(4):558-66. doi: 10.1016/j.ctrv.2013.10.001. Epub 2013 Oct 15. Review.

PMID:
24176790
24.

Prognostic and predictive biomarkers in early stage NSCLC: CTCs and serum/plasma markers.

Crosbie PA, Shah R, Summers Y, Dive C, Blackhall F.

Transl Lung Cancer Res. 2013 Oct;2(5):382-97. doi: 10.3978/j.issn.2218-6751.2013.09.02. Review.

25.

Sarcomatoid mesothelioma with osteoid differentiation.

Evison M, Crosbie PA, Howe M, Booton R.

J Thorac Oncol. 2013 Sep;8(9):1222-3. doi: 10.1097/JTO.0b013e31829f6b2c. No abstract available.

26.

Should we give long-term macrolide therapy for COPD?

Crosbie PA, Woodhead M.

Thorax. 2013 Oct;68(10):966. doi: 10.1136/thoraxjnl-2013-203766. Epub 2013 May 25. No abstract available.

PMID:
23708008
27.

Topographical study of O(6)-alkylguanine DNA alkyltransferase repair activity and N7-methylguanine levels in resected lung tissue.

Crosbie PA, Harrison K, Shah R, Watson AJ, Agius R, Barber PV, Margison GP, Povey AC.

Chem Biol Interact. 2013 Jul 5;204(2):98-104. doi: 10.1016/j.cbi.2013.04.013. Epub 2013 May 9.

PMID:
23665414
28.

Elevated N3-methylpurine-DNA glycosylase DNA repair activity is associated with lung cancer.

Crosbie PA, Watson AJ, Agius R, Barber PV, Margison GP, Povey AC.

Mutat Res. 2012 Apr 1;732(1-2):43-6. doi: 10.1016/j.mrfmmm.2012.01.001. Epub 2012 Jan 14.

PMID:
22266085
29.

GSTM1 copy number and lung cancer risk.

Crosbie PA, Barber PV, Harrison KL, Gibbs AR, Agius RM, Margison GP, Povey AC.

Mutat Res. 2009 May 12;664(1-2):1-5. doi: 10.1016/j.mrfmmm.2009.01.006. Epub 2009 Feb 4.

PMID:
19428374
30.

Long-term macrolide therapy in chronic inflammatory airway diseases.

Crosbie PA, Woodhead MA.

Eur Respir J. 2009 Jan;33(1):171-81. doi: 10.1183/09031936.00042208. Review.

31.

Association between lung cancer risk and single nucleotide polymorphisms in the first intron and codon 178 of the DNA repair gene, O6-alkylguanine-DNA alkyltransferase.

Crosbie PA, McGown G, Thorncroft MR, O'Donnell PN, Barber PV, Lewis SJ, Harrison KL, Agius RM, Santibáñez-Koref MF, Margison GP, Povey AC.

Int J Cancer. 2008 Feb 15;122(4):791-5.

32.

No association between N7-methyldeoxyguanosine and 8-oxodeoxyguanosine levels in human lymphocyte DNA.

Harrison KL, Crosbie PA, Agius RM, Barber PV, Carus M, Margison GP, Povey AC.

Mutat Res. 2006 Aug 30;600(1-2):125-30. Epub 2006 Jun 12.

PMID:
16765387
33.

A rare complication of pneumonectomy: diagnosis made by a literature search.

Crosbie PA, Cooper AN, Ray S, O'Driscoll R.

Respir Med. 2005 Sep;99(9):1198-200. Epub 2005 Mar 23.

Supplemental Content

Loading ...
Support Center